Commenting open until 3/18 on draft Community Group Report about a minimum representation of potential drug-drug interaction knowledge and evidence

Hi,

I have received responses from folks interested in providing input on the draft Community Group Report about a minimum representation of potential drug-drug interaction knowledge and evidence.

All are welcome to provide feedback. So there is a deadline, I will leave the comment period open for 3 weeks,  until 3/18/2019.

thank you very much,
-Rich


On 2/25/19 12:42 PM, Richard Boyce wrote:
Sorry for one more email --- it was pointed out to me that the version on the public server was not current. The correct version is now out there and dated  25 February 2019:

https://dbmi-icode-01.dbmi.pitt.edu/dikb-evidence/hcls-drug-drug-interaction/index.html


Alternatively, you can view it locally on your machine after downloading it from github:

https://github.com/w3c/hcls-drug-drug-interaction/


-R

On 2/25/19 12:35 PM, Richard Boyce wrote:
My apologies for providing the wrong link to the draft note. Here is the correct one:

https://dbmi-icode-01.dbmi.pitt.edu/dikb-evidence/hcls-drug-drug-interaction/index.html



-R

On 2/23/19 1:51 PM, Richard Boyce wrote:
Hello,

Would anyone interested please take a look at our draft Semantic Web in Health Care and Life Sciences Community Group Report?  It is  titled "Minimum Representation of Potential Drug-Drug Interaction Knowledge and Evidence - Technical and User-centered Foundation Specification." The abstract of this Report is copied below. The Report  is the culmination of more than 2 years of effort by a volunteer multidisciplinary task force. We feel that this is very close to being ready to publish.

The full draft of the note is located here:

http://localhost/~rdb20/hcls-drug-drug-interaction/


Feel free to email feedback to this list or post issues on the project's github: https://github.com/w3c/hcls-drug-drug-interaction/


Abstract:

The purpose of this Community Group Note is to provide a technical and user-centered foundation for a minimum information model for information about potential drug-drug interactions. The Note provides non-ambigous definitions for 10 core information items. It also provides 8 detailed best practice recommendations related to the 10 core information items. The definitions and recommendations are shown as both narrative and prototype JSON artifacts using 2 exemplar potential drug-drug interactions. Adoption of the recommendations by developers of PDDI knowledge artifacts will improve the usefulness of the artifacts within clinical workflows. Intended downstream applications include clinical decision support, drug product label enhancement, cohort identification, and other activities relevant to protecting patients from harm from drug interactions.






--
Richard D Boyce, PhD
Associate Professor of Biomedical Informatics and Clinical and Translational Science in the Clinical and Translational
Science Institute
Director of the Informatics Core for the Center of Excellence for Natural Product- Drug Interaction Research (NaPDI)
Faculty, Center for Pharmaceutical Policy and Prescribing
Faculty, Geriatric Pharmaceutical Outcomes and Gero-Informatics Research and Training Program
University of Pittsburgh
rdb20@pitt.edu<mailto:rdb20@pitt.edu>
Office: 412-648-9219
Twitter: @bhaapgh